Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.79 USD | -1.64% | +1.97% | +70.55% |
01:02pm | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01:00pm | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.55% | 505M | |
+2.91% | 108B | |
+10.26% | 105B | |
+1.57% | 23.46B | |
-12.23% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.74% | 17.19B | |
+6.34% | 13.99B | |
+36.81% | 12.53B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Citigroup Adjusts Price Target on Larimar Therapeutics to $10 From $4.50, Maintains Buy Rating